| Q78171298 | Another case of focal segmental glomerulosclerosis in an acutely uraemic patient following interferon therapy |
| Q28070279 | Anti-hepatitis C virus drugs and kidney |
| Q32060398 | Anticancer drug-induced kidney disorders |
| Q40390091 | Clinical toxicity of the interferons. |
| Q33370676 | Complementary treatments of chronic viral hepatitis C |
| Q37816412 | Emergence of biomarkers in nephropharmacology |
| Q35022117 | Essential thrombocythemia (ET): moving from palliation to cure |
| Q42965148 | Ribavirin induced anaemia: the effect of vitamin D supplementation on erythropoietin and erythrocyte indices in normal Wistar rat. |
| Q42368351 | Thrombotic microangiopathy induced by interferon beta in patients with multiple sclerosis: three cases treated with eculizumab. |
| Q26784321 | Vitamin D and chronic hepatitis C: effects on success rate and prevention of side effects associated with pegylated interferon-α and ribavirin |